Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Treated with Nivolumab

J Thorac Oncol. 2017 Sep;12(9):e140-e141. doi: 10.1016/j.jtho.2017.04.027.

Authors

Tomoko Funazo¹, Takashi Nomizo², Young Hak Kim²

Affiliations

¹ Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: [email protected].
² Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

PMID: 28838713
DOI: 10.1016/j.jtho.2017.04.027

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
Female
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Male
Neoplasm Metastasis
Nivolumab / pharmacology
Nivolumab / therapeutic use*
Progression-Free Survival

Substances

Antineoplastic Agents, Immunological
Nivolumab